Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)

计划入组 12 人 · 首次发布于 2024 年 6 月 17 日

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

计划入组 82 人 · 首次发布于 2023 年 10 月 10 日

Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT

计划入组 206 人 · 首次发布于 2010 年 11 月 2 日

Glial growth factor 2

rhGDG-5

rHCG (Unico Health)

RYGG TRADING PTY LTD

Australia

Candel Therapeutics Highlights Pipeline Momentum with CAN-2409 and CAN-3110

FDA Grants Fast Track Designation to Zotiraciclib for IDH-Mutant Recurrent High-Grade Glioma

Candel Therapeutics Strengthens Board with Industry Veteran Ahead of Key BLA Submission